THIS IS AWESOME NEWS IMO
Omicron Retains Spencer Edwards, Inc. to Secure a Major Private
Placement Financing
BELLINGHAM, Wash.--(BUSINESS WIRE)--Oct. 26, 1999--Omicron Technologies, Inc. (OTC BB: OGPS) is pleased to announce that the company has
retained Spencer Edwards, Inc., a brokerage firm based in Englewood, Colorado, in an investment banking and advisory capacity.
Spencer Edwards' primary purpose is to increase the value of the company's securities, to obtain adequate financing and increase shareholder value. Spencer
Edwards will assist the company to identify, refer, and negotiate potential merger and acquisition candidates and other business transactions on behalf of the
company.
Spencer Edwards has agreed to raise up to $9 million in private placement financing and more if required. The $9 million private placement will be released to the
company in tranches to meet the budgetary requirements over the next 6 months. As compensation for the financing, Spencer Edwards will receive a half warrant for
every share issued. Each warrant will have an exercise price of $4 per share.
Omicron Technologies, Inc. is in the business of acquisition, research and development, and marketing of leading edge technologies and Internet-based business
concepts. Through a combined strategy of focusing on specific marketing niches and speedy development of its proprietary technologies, Omicron expects to gain
significant market penetration in these areas.
OMICRON TECHNOLOGIES, INC.
Barrett Sleeman, President
NOTE: Safe Harbor for Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor
provisions of the Private Securities Litigation Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause the
company's actual results in the future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, volatility of prices,
product demand, market compensation, risk inherent in the company's international operations, imprecision of reserve estimates and the company's ability to replace
and expand reserves.
Contact:
Omicron Technologies
Investor Relations
Toll-free: 877-903-2288
Web sites: www.omicrontechnologies.com
|
